Welcome to iAluRil.co.uk
iAluRil contains three active components: 800 mg/50 ml sodium hyaluronate (1.6%), and 1 g /50 ml sodium chondroitin sulfate (2%) and calcium chloride (0.87%).
iAluRil can be used for the treatment of:
– Interstitial cystitis
– Painful bladder syndrome
– Recurrent urinary tract infections
– Chemical-/radiation-induced cystitis (including BCG)
iAluRil® is the first intravesical GAG replacement therapy to combine one of the most abundant sulfated GAG molecules located on the bladder wall,2 chondroitin sulfate, with the most integral component of the GAG layer,3 hyaluronic acid. This combination is designed to facilitate faster and more effective restoration of the bladder epithelium.
1) iAluRil Prefill Patient Information. 2) Hurst RE et al. Functional and Structural Characteristics of the Glycosaminoglycans of the Bladder Luminal Surface. J Urol 1987; 138 (2): 433-437. 3) Stryer L. Biochemistry – 4th Edition. W.H. Freeman & Company; 1995. 4. Parsons CL et al. Abnormal Sensitivity to Intravesical Potassium in Interstitial Cystitis and Radiation Cystitis. Neurourol Urodyn 1994; 13(5): 515-520. 5. Damiano R et al. Prevention of Recurrent Urinary Tract Infections by Intravesical Administration of Hyaluronic Acid and Chondroitin Sulfate: a Placebo-Controlled Randomised Trial. Eur Urol 2011; 59(4): 645-651. 2011; 59(4): 645-651.
DEPENDABLE SUPPLY CHAIN.
For further information please call: 01730 231148,
email: firstname.lastname@example.org or visit www.aspirepharma.co.uk